Moderna
MRNA
MRNA
957 hedge funds and large institutions have $30.2B invested in Moderna in 2023 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 308 increasing their positions, 375 reducing their positions, and 120 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less capital invested
Capital invested by funds: $38.4B → $30.2B (-$8.25B)
22% less funds holding in top 10
Funds holding in top 10: 18 → 14 (-4)
36% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 120
Holders
957
Holding in Top 10
14
Calls
$1.31B
Puts
$1.46B
Top Buyers
| 1 | +$105M | |
| 2 | +$102M | |
| 3 | +$76.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$64.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.7M |
Top Sellers
| 1 | -$2.59B | |
| 2 | -$166M | |
| 3 | -$113M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$91.7M |
| 5 |
Jane Street
New York
|
-$90.4M |